Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2008
05/01/2008US20080102477 Method for screening an anticancer drug using acetylated BubR1
05/01/2008US20080102476 Analyzing Histamine H4 Receptor-Mediated Effects In Whole Blood
05/01/2008US20080102475 Alternatively spliced isoform of phosphodiesterase 4B (PDE4B)
05/01/2008US20080102474 Detection of a Therapeutic Antibody in an Experimental Animal
05/01/2008US20080102473 Method and system to improve contrast in lateral flow assay
05/01/2008US20080102468 Using overexpression of tumor polypeptide UNQ733 as diagnostic indicator of cell proliferative disorders
05/01/2008US20080102464 Method and device to probe a membrane by applying an in-plane electric field
05/01/2008US20080102462 Device and method for multiple analyte detection
05/01/2008US20080102458 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains
05/01/2008US20080102457 Target Protein And Target Gene In Drug Designing And Screening Method
05/01/2008US20080102451 Using concentration of tumor marker antigens as predictive tool in determining efficacy of anti-endothelin-1 therapy in treatment of cancer
05/01/2008US20080102442 Surface sampling apparatus which increases number of discrete sites at which samples taken; food safety
05/01/2008US20080102440 Pressure sensing apparatus comprising neuronal cells for use in analyzing underwater acoustics
05/01/2008US20080102175 Cooking apparatus and method of displaying caloric information
05/01/2008US20080102088 against tularemia; subcellular protein expressed from Francisella tularensis infected mammal subculture growing in synthetic salts medium of weak acidity
05/01/2008US20080102076 Immunostimulatory Compositions and Uses Thereof
05/01/2008US20080102075 Enzymatic polypeptide which cleaves tumor necrosis factor receptor for use in treatment and prevention of arthritis and inflammatory disorders
05/01/2008US20080102072 Cytokine specific immunoglobulin for prevention and treatment of diabetes, autoimmune and inflammatory disorders
05/01/2008US20080102070 SCDs As Modifiers of the p53 Pathway and Methods of Use
05/01/2008US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
05/01/2008US20080102057 Bipotential liver cell lines from wild-type mammalian liver tissue
05/01/2008US20080102055 Method for detecting Alzheimer's disease
05/01/2008US20080102036 Biocompatible Fluorescent Silicon Nanoparticles
05/01/2008US20080102027 Targer For B-Cell Disorders
05/01/2008US20080101990 Reaction cuvette wash unit
05/01/2008US20080101989 Methods, Compositions and Kits Pertaining to Analyte Determination
05/01/2008US20080101434 Sensor device and method for qualitative and quantitative analysis of gas phase substances
05/01/2008US20080100971 Biosensor and sensing cell array using the same
05/01/2008US20080100279 Nano-Based Device for Detection of Disease Biomarkers and Other Target Molecules
05/01/2008US20080099332 Analyte Monitoring Devices
05/01/2008US20080099331 Solid-state urea biosensor and its data acquisition system
05/01/2008US20080099241 Characterizing a reservoir in connection with drilling operations
05/01/2008US20080098802 System and method for analyte measurement
05/01/2008US20080098795 Accurate in line oxygen monitoring of patient ventilator operation; drift correction
05/01/2008US20080098794 Apparatus and method for calibrating a trace detection portal
04/2008
04/30/2008EP1916527A1 Analysis of mass spectral data in the quiet zones
04/30/2008EP1916526A1 Method for diagnostic and therapeutic target discovery by combining isotopic and isobaric labels
04/30/2008EP1916525A1 Method for detection of yeast cell wall
04/30/2008EP1916524A1 Rotatable test element
04/30/2008EP1916519A2 Marker detection apparatus and marker detection method
04/30/2008EP1916518A2 Marker detection apparatus and marker detection method
04/30/2008EP1916310A1 Method for analysis of nkt cell function
04/30/2008EP1916309A2 Surface treatment of carbon composite material to improve electrochemical properties
04/30/2008EP1916304A2 Antigenic polypeptides associated with multiple sclerosis and uses
04/30/2008EP1916301A1 Method for evaluating compound using molecule on the rb pathway as index and molecular diagnostic method
04/30/2008EP1916297A2 Cell separation compositions and methods
04/30/2008EP1916256A2 Search for cancer markers by a novel screening method
04/30/2008EP1915990A1 Sustained release preparation
04/30/2008EP1915626A2 Apoptosis sensitivity to apo2l/trail by testing for galnac-t14 expression in cells/tissues
04/30/2008EP1915625A2 Apoptosis sensitivity to apo2l/trail by testing for galnac-t14 expression in cells/tissues
04/30/2008EP1915624A1 Amyloid beta receptor and uses thereof
04/30/2008EP1915623A2 Hematopoietic cell phenotyping using circulating cell-free markers
04/30/2008EP1915622A2 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex
04/30/2008EP1915621A2 Methods and compositions for diagnosis and treatment of viral and bacterial infections
04/30/2008EP1915620A1 DIAGNOSIS, TREATMENT, AND PREVENTION OF VASCULAR DISORDERS USING IL-1alpha AUTOANTIBODIES
04/30/2008EP1915619A2 Method for carrying out homogeneous phase detection, in particular, for detecting the progesterone in the milk of a mammal and corresponding kit
04/30/2008EP1915618A2 Analysis using microfluidic partitioning devices
04/30/2008EP1915617A2 Methods and compositions for identifying a peptide having an intermolecular interaction with a target of interest
04/30/2008EP1915616A1 An immuno conjugate and process for preparation thereof
04/30/2008EP1915615A2 Method to determine predictive tests and device applying same to lubricant formulations
04/30/2008EP1915614A2 Methods of detecting and treating acute kidney injury
04/30/2008EP1915613A2 Methods for monitoring neuroinflammatory destruction of neurons and for treating diseases having an inflammatory component related to phospholipase a2
04/30/2008EP1915610A2 Bioassays using plasmonic scattering from noble metal nanostructures
04/30/2008EP1915606A1 Sample holder for dynamic light scattering
04/30/2008EP1915466A2 Methods for preparing hybrid substrates comprising dna and antibodies and uses thereof
04/30/2008EP1915463A2 Nanoparticles for manipulation of biopolymers and methods thereof
04/30/2008EP1915460A2 Method for predicting the response to a treatment with a her dimerization inhibitor
04/30/2008EP1915457A2 Methods and compositions for determining a level of biologically active serum paraoxonase
04/30/2008EP1915456A1 Cancerous disease modifying antibodies
04/30/2008EP1915455A1 Cancerous disease modifying antibodies
04/30/2008EP1915423A2 Silylamine modified nanoparticulate carriers
04/30/2008EP1915398A2 Human anti-b7rp1 neutralizing antibodies
04/30/2008EP1915397A2 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders
04/30/2008EP1915395A2 Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
04/30/2008EP1915391A1 Sra binding protein
04/30/2008EP1915162A1 Modulators
04/30/2008EP1730526A4 Fluorescence polarization assay
04/30/2008EP1711831B1 Method of diagnosing sepsis by detecting selectively the concentration of superoxide dismutase 1 (sod-1) in samples
04/30/2008EP1711823B1 Detection of biomolecules using porous biosensors and raman spectroscopy
04/30/2008EP1677100A4 Equilibrium bomb for studying phase behaviour of hydrocarbons
04/30/2008EP1673465A4 Methods and compositions for the diagnosis of sepsis
04/30/2008EP1664325A4 Mass spectrometry methods for simultaneous detection of metabolic enzyme activity and metabolite levels
04/30/2008EP1636582A4 Liquid permeable composition in dry reagent devices
04/30/2008EP1635691A4 Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis
04/30/2008EP1613955B1 Biosensor system
04/30/2008EP1604211B1 Identification of therapeutic compounds
04/30/2008EP1601953B1 Production of holographic sensors
04/30/2008EP1406927B1 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
04/30/2008EP1307736B1 A quantitative, high-throughput screening method for protein stability
04/30/2008EP1307486B1 Somatostatin analogues
04/30/2008EP1277055B1 Biochip for the archiving and medical laboratory analysis of biological sample material
04/30/2008EP1234187B1 Method, apparatus, media and signals for identifying associated cell signaling proteins
04/30/2008EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization
04/30/2008EP1183360B1 Modified cytokine for its stabilisation
04/30/2008EP1127072B1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla
04/30/2008EP1060395B1 Microarrays and uses therefor
04/30/2008EP1058728B1 V-like domain binding molecules
04/30/2008DE20321610U1 Probenvorbereitungsvorrichtung und hierauf aufbauender Testgerätesatz Sample preparation device and thereafter act building test equipment set
04/30/2008DE202007016343U1 Vorrichtungssystem zur schnellen Bestimmung von Substanzen in Flüssigkeiten mit Hilfe eines Rechner-gekoppelten Videosystems A device system for rapid determination of substances in liquids with the aid of a computer-coupled video system
04/30/2008DE202006019723U1 System zur Prüfung der Kühlschmierstoff-Filterung System to check the coolant filtering